Bcl-2 Antibody
- 貨號 Cat. No.
- 3195-100
- 規格 Size
- 100 µg
Description
pstrongAntibody Target :/strongBcl-2/p
pstrongHost: Mouse /strong/p
pstrongAntibody Type: Monoclonal /strong/p
pstrongIsotype: Mouse IgG1 /strong/p
pstrongAntibody Form: Affinity Purified Antibody /strong/p
pstrongImmunogen Sequence: Synthetic peptide corresponding to resides surrounding a.a. 44 of Human Bcl-2 /strong/p
pstrongAccession#: M13994 /strong/p
pstrongGene ID: 596 /strong/p
pstrongAppearance: Colorless liquid /strong/p
pstrongConcentration: 0.5 mg/ml /strong/p
pstrongFormulation: 100 micro;g (0.5 mg/ml) protein A purified from (low FBS containing) tissue culture supernatant. Purity was gt;95%. The antibody was formulated in PBS containing 1 mg/ml BSA and 1.5 mM sodium azide and 50% glycerol /strong/p
pstrongPurification: Affinity purified /strong/p
pstrongSpecies Reactivity: hu /strong/p
pstrongApplication: WB/IP/IHC /strong/p
pstrongApplication amp; Usage: Western blot (1-4 micro;g/ml), Immunoprecipitation, Immunohistochemistry, and Flow cytometry. However the optimal conditions should be determined individually. Recognize the 26 kDa human Bcl-2 /strong/p
pstrongStorage Temp.: -20 deg;C /strong/p
pstrongShipping : gel pack /strong/p
pstrongShelf Life: 12 months /strong/p
pstrongHandling: The antibody solution should be gently mixed before use. /strong/p
pstrongBrief Background Descriptions: Bcl-2 (B-cell leukemia/lymphoma 2) gene was discovered by walking the chromosomal breakpoints t(14;18). This gene consists of two exons and several transcripts that encode two different protein products, Bcl-2alpha; and Bcl-2beta;. Both proteins are approximately 26-30 kDa and differ at their C-terminal region. Bcl-2 suppresses apoptosis (programmed cell death) and this property appears to be modulated by homodimerization or association with Bax and Bad, two cell death promoters/strong/p
pstrongHost: Mouse /strong/p
pstrongAntibody Type: Monoclonal /strong/p
pstrongIsotype: Mouse IgG1 /strong/p
pstrongAntibody Form: Affinity Purified Antibody /strong/p
pstrongImmunogen Sequence: Synthetic peptide corresponding to resides surrounding a.a. 44 of Human Bcl-2 /strong/p
pstrongAccession#: M13994 /strong/p
pstrongGene ID: 596 /strong/p
pstrongAppearance: Colorless liquid /strong/p
pstrongConcentration: 0.5 mg/ml /strong/p
pstrongFormulation: 100 micro;g (0.5 mg/ml) protein A purified from (low FBS containing) tissue culture supernatant. Purity was gt;95%. The antibody was formulated in PBS containing 1 mg/ml BSA and 1.5 mM sodium azide and 50% glycerol /strong/p
pstrongPurification: Affinity purified /strong/p
pstrongSpecies Reactivity: hu /strong/p
pstrongApplication: WB/IP/IHC /strong/p
pstrongApplication amp; Usage: Western blot (1-4 micro;g/ml), Immunoprecipitation, Immunohistochemistry, and Flow cytometry. However the optimal conditions should be determined individually. Recognize the 26 kDa human Bcl-2 /strong/p
pstrongStorage Temp.: -20 deg;C /strong/p
pstrongShipping : gel pack /strong/p
pstrongShelf Life: 12 months /strong/p
pstrongHandling: The antibody solution should be gently mixed before use. /strong/p
pstrongBrief Background Descriptions: Bcl-2 (B-cell leukemia/lymphoma 2) gene was discovered by walking the chromosomal breakpoints t(14;18). This gene consists of two exons and several transcripts that encode two different protein products, Bcl-2alpha; and Bcl-2beta;. Both proteins are approximately 26-30 kDa and differ at their C-terminal region. Bcl-2 suppresses apoptosis (programmed cell death) and this property appears to be modulated by homodimerization or association with Bax and Bad, two cell death promoters/strong/p